South Carolina Bill Rejecting FDA Restrictions on Terminal Patients Passes Senate 41-0
COLUMBIA, S.C. (Feb. 29, 2016) – A South Carolina bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients unanimously passed the Senate last week. Pre-filed on Dec. 2 by Rep. Paul G. Campbell (R-Berkeley), Senate Bill 929…